ATHA

0.576

5.11% 0.028

Dopo l'orario di chiusura: .58 0.004 +0.69%

Athira Pharma Inc (ATHA)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

$0.548

Aprire:

$0.5455

Volume 24 ore:

221.72K

Relative Volume:

0.05

Capitalizzazione di mercato:

$22.27M

Reddito:

Utile/perdita netta:

$-117.67M

Rapporto P/E:

-0.2035

EPS:

-2.83

Flusso di cassa netto:

$-101.06M

1 W Prestazione:

-1.52%

1M Prestazione:

-10.32%

6M Prestazione:

-74.85%

1 anno Prestazione:

-72.57%

Intervallo 1D:

$0.52

$0.576

Intervallo di 1 settimana:

$0.52

$0.609

Portata 52W:

$0.4115

$4.2984

Athira Pharma Inc Stock (ATHA) Company Profile

Nome

Athira Pharma Inc

Settore

Healthcare (1176)

Industria

Biotechnology (673)

Telefono

(425) 620-8501

Indirizzo

18706 NORTH CREEK PARKWAY, SUITE 104, BOTHELL

Dipendente

Cinguettio

Prossima data di guadagno

2024-12-07

Ultimi documenti SEC

ATHA's Discussions on Twitter

Confronta ATHA con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
ATHA Athira Pharma Inc	0.576	22.27M	0	-117.67M	-101.06M	-3.09
VRTX Vertex Pharmaceuticals Inc	397.27	102.31B	10.63B	-479.80M	-1.35B	-1.99
REGN Regeneron Pharmaceuticals Inc	701.85	77.13B	13.85B	4.65B	3.32B	40.41
ARGX Argen X Se Adr	623.82	37.30B	1.86B	-40.29M	-1.28B	-0.85
ALNY Alnylam Pharmaceuticals Inc	245.44	31.66B	2.09B	-332.26M	16.06M	-2.62
BNTX Biontech Se Adr	113.08	27.11B	3.30B	-501.07M	1.03B	-2.1146

Athira Pharma Inc Stock (ATHA) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-09-19	Downgrade	Mizuho	Outperform → Neutral
2024-09-04	Downgrade	BTIG Research	Buy → Neutral
2024-09-04	Downgrade	JMP Securities	Mkt Outperform → Mkt Perform
2024-09-04	Downgrade	Rodman & Renshaw	Buy → Neutral
2024-08-19	Iniziato	Rodman & Renshaw	Buy
2022-10-17	Aggiornamento	JMP Securities	Mkt Perform → Mkt Outperform
2022-07-07	Iniziato	Mizuho	Buy
2022-06-23	Downgrade	JMP Securities	Mkt Outperform → Mkt Perform
2022-06-23	Downgrade	Jefferies	Buy → Hold
2022-06-23	Downgrade	Stifel	Buy → Hold
2022-05-10	Iniziato	BTIG Research	Buy
2022-04-21	Iniziato	Berenberg	Buy
2021-12-15	Iniziato	Goldman	Neutral
2020-10-13	Iniziato	Goldman	Buy
2020-10-13	Iniziato	JMP Securities	Mkt Outperform
2020-10-13	Iniziato	Jefferies	Buy
2020-10-13	Iniziato	Stifel	Buy

Mostra tutto

Athira Pharma Inc Borsa (ATHA) Ultime notizie

Dec 18, 2024

Athira Pharma Insider Ups Holding By 111% During Year - Yahoo Finance

Dec 18, 2024

Dec 12, 2024

Athira Pharma's SWOT analysis: stock faces challenges after trial setback - Investing.com

Dec 12, 2024

Dec 06, 2024

Athira Pharma Presents Preclinical Data Highlighting Neuroprotective Effects of ATH-1105 in Models of ALS at Motor Neurone Disease Association’s 35th International Symposium on ALS/MND - GlobeNewswire

Dec 06, 2024

Nov 25, 2024

Athira Pharma, Inc. (NASDAQ:ATHA) Shares Bought by GSA Capital Partners LLP - Defense World

Nov 25, 2024

Crowdstrike Holdings Inc (CRWD-Q) QuotePress Release - The Globe and Mail

Nov 25, 2024

Nov 12, 2024

Athira Pharma's SWOT analysis: stock shifts focus after trial setback By Investing.com - Investing.com UK

Nov 12, 2024

Athira Pharma's SWOT analysis: stock shifts focus after trial setback - Investing.com

Nov 12, 2024

Nov 11, 2024

Athira Pharma’s Regulatory Compliance Challenges Threaten Drug Development Pipeline - MSN

Nov 11, 2024

Nov 08, 2024

Athira exploring strategic alternatives after Alzheimer’s failure - BioPharma Dive

Nov 08, 2024

Athira Pharma Reports Q3 2024 Financial Results - TipRanks

Nov 08, 2024

Nov 07, 2024

Athira Pharma Reports Third Quarter 2024 Financial Results and Pipeline and Business Updates - The Manila Times

Nov 07, 2024

Nov 05, 2024

What You Didn’t Know About Athira Pharma Inc (NASDAQ: ATHA) This Week - Stocks Register

Nov 05, 2024

Nov 04, 2024

Errors Lower Fee Award For Athira Pharma Investors' Counsel - Law360

Nov 04, 2024

US Penny Stocks: November 2024's Top Picks To Consider - Simply Wall St

Nov 04, 2024

Nov 01, 2024

Why Charter Communications Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket - Benzinga

Nov 01, 2024

Oct 31, 2024

Perceptive Advisors LLC Acquires Significant Stake in Athira Pha - GuruFocus.com

Oct 31, 2024

Oct 26, 2024

ATHA Stock Tanks as Alzheimer's Study Fails to Meet Primary Goal - MSN

Oct 26, 2024

Oct 22, 2024

Athira Pharma to Present Results from Phase 2/3 LIFT-AD - GlobeNewswire

Oct 22, 2024

Athira Pharma to Present Results from Phase 2/3 LIFT-AD Clinical Trial of Fosgonimeton at the Clinical Trials on Alzheimer’s Disease (CTAD) 2024 Meeting - StockTitan

Oct 22, 2024

Oct 18, 2024

Athira Pharma faces Nasdaq delisting over share price - Investing.com

Oct 18, 2024

Oct 16, 2024

A closer look at Athira Pharma Inc (ATHA)’s stock price trends - US Post News

Oct 16, 2024

Oct 07, 2024

A year in review: Athira Pharma Inc (ATHA)’s performance in the last year - US Post News

Oct 07, 2024

A Guide To The Risks Of Investing In Athira Pharma Inc (ATHA) - Knox Daily

Oct 07, 2024

Analytical Overview: Athira Pharma Inc (ATHA)’s Ratios Tell a Financial Story - The Dwinnex

Oct 07, 2024

Sep 29, 2024

Athira Pharma, Inc. (NASDAQ:ATHA) Shares Bought by Forefront Analytics LLC - Defense World

Sep 29, 2024

Sep 27, 2024

Wall Street SWOT: Athira Pharma stock faces crossroads after Alzheimer's trial setback - Investing.com

Sep 27, 2024